non fda approved semaglutide shortage ends as sets deadline for compounders U.S. FDA finds no evidence

For routine handling, keep vials at 28 C and return them promptly to refrigerated storage after each use to minimize cumulative room-temperature exposure

Additionally, clinical trials are needed to evaluate the safety, efficacy, and long-term impact of GLP-1 receptor agonists on cancer progression, survival, and quality of life, particularly in patients with comorbidities like diabetes and obesity

Retatrutide: Why the Triple-Receptor Approach Is Getting Attention Retatrutide is attracting attention because it is being studied as a triple hormone receptor agonist

Still, some may hit a plateau where weight loss slows down

When to Pause Your Dose and Seek Provider Support While most semaglutide side effects are mild and temporary, persistent vomiting that prevents you from eating or drinking, severe abdominal pain, or signs of dehydration (dark urine, extreme dizziness) warrant immediate contact with your provider